New Discoveries Elucidate Gut–Brain Pathways in Chronic Pain Management
A groundbreaking study uncovers the neural pathways responsible for transmitting pain signals from the gut to the brain, offering new avenues for effective IBS and IBD treatments. Learn how these insights could revolutionize chronic pain management.
Recent research from the South Australian Health and Medical Research Institute (SAHMRI) has shed new light on how nerve signals from the gut are transmitted to the brain, revealing potential targets for treating conditions such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). These conditions, which afflict approximately 12% of Australians, involve overactive or hypersensitive nerves within the gastrointestinal tract, leading to chronic pain and discomfort. Despite the high prevalence, current treatment options remain limited.
Published in the Journal of Neurochemistry, the collaborative study involved researchers from the University of Adelaide, the University of Melbourne, and Flinders University. Led by Dr. Andrea Harrington, the research identified two distinct neural pathways within the spinal cord that serve as critical 'gatekeepers' for pain signals traveling from the colon and rectum to the brainstem.
Dr. Harrington explained that sensory information from the colorectum is conveyed to the brainstem via two separate regions of the spinal cord: one in the thoracolumbar spinal cord, responsible for transmitting noxious, pain-related signals, and another in the lumbosacral spinal cord, which carries a broader spectrum of signals related to normal gut function and pain modulation.
This discovery enhances our understanding of how the nervous system processes gut signals and how abnormal pain perception may develop. The detailed visualization of these pathways was made possible through advanced imaging supported by Adelaide Microscopy and histology services.
Moving forward, researchers aim to examine how these neural pathways are altered in IBS and IBD, with the goal of developing targeted therapies that can modify or inhibit faulty pathways, thereby alleviating chronic pain.
This breakthrough paves the way for more precise interventions in gastrointestinal disorders, potentially transforming how chronic gut pain is managed in the future.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Research Highlights How Diabetes Alters Heart Structure and Function
A recent study reveals how type 2 diabetes induces molecular and structural changes in the heart, increasing the risk of heart failure. Researchers highlight potential pathways for targeted therapies to improve cardiovascular outcomes in diabetic patients.
Emerging Evidence Supports Minimalist Technique in Transcatheter Aortic Valve Replacement
Latest research at ESC Congress 2025 confirms the safety and efficacy of a minimalist, sedation-free approach to transcatheter aortic valve implantation, offering benefits over traditional methods.
Innovative Drug Shows Promise in Managing Resistant Hypertension
A new clinical trial highlights lorundrostat's potential to safely lower blood pressure in patients with resistant hypertension, marking a significant advancement in targeted hypertension therapy.
Innovative Digital Cognitive Test Enhances Early Detection of Alzheimer’s Disease in Primary Care
A new digital cognitive assessment developed by Lund University improves early Alzheimer’s detection in primary care, offering a fast, objective, and accessible tool to identify patients who need further testing for the disease.